Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.62 -0.01 (-1.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mira Pharmaceuticals (MIRA) Other Accumulated Expenses (2022 - 2025)

Updated

Mira Pharmaceuticals (MIRA) reported Other Accumulated Expenses of $572,865 for the quarter ended Dec 31, 2025.

Analysis

Mira Pharmaceuticals (MIRA) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

Dating back to the quarter ended Dec 31, 2022, Mira Pharmaceuticals' Other Accumulated Expenses record includes 6 quarters.

  • Other Accumulated Expenses has a three-year compound annual growth rate of 194.0% (years ended Dec 2022 to Dec 2025).
  • By year, Other Accumulated Expenses came in at $14,472 in the year ended Dec 31, 2023 (-35.8%) and $22,534 in the year ended Dec 31, 2022.
  • The figure for the quarter ended Dec 31, 2025 ranks as the lowest quarterly Other Accumulated Expenses since the quarter ended Mar 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Mira Pharmaceuticals 14.69 Mn -5.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 572,865.00
Sep 30, 2023 14,592.00
Jun 30, 2023 39,611.00
Dec 31, 2022 22,534.00
API Access

Mira Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MIRA&period=max&api_key=YOUR_API_KEY